Quetiapine and Wolff-Parkinson-White Syndrome [PDF]
Quetiapine is occasionally associated with cardiovascular adverse effects such as QTc prolongation. QTc prolongation is a side effect that requires monitoring in order to avoid more serious cardiac complications.
Michael Chen+5 more
doaj +2 more sources
Atrioventricular and Ventriculoatrial Excitation in Wolff‐Parkinson‐White Syndrome (Type B): Temporary Ablation at Surgery [PDF]
A patient with an atrial septal defect, paroxysmal tachycardia, and the Wolff-Parkinson-White syndrome (type B) had epicardial exploration to determine the nature of the excitation anomaly.
H. Burchell+3 more
semanticscholar +2 more sources
Paradoxical Use of a Demand Pacemaker in Treatment of Supraventricular Tachycardia Due to the Wolff‐Parkinson‐White Syndrome: Observation on Termination of Reciprocal Rhythm [PDF]
This paper describes a new technique for terminating attacks of supraventricular tachycardia in a patient with Wolff-Parkinson-White syndrome by using a demand pacemaker.
G. F. Ryan+3 more
semanticscholar +2 more sources
The History of the Wolff–Parkinson–White Syndrome [PDF]
While Drs Wolff, Parkinson, and White fully described the syndrome in 1930, prior case reports had described the essentials. Over the ensuing century this syndrome has captivated the interest of anatomists, clinical cardiologists, and cardiac surgeons ...
Melvin M. Scheinman
doaj +4 more sources
Radiofrequency Catheter Ablation of Accessory Atrioventricular Connections in 250 Patients: Abbreviated Therapeutic Approach to Wolff‐Parkinson‐White Syndrome [PDF]
Background The purpose of this study was to report the results and complications of radiofrequency catheter ablation of accessory atrioventricular (AV) connections by using an abbreviated approach aimed at minimizing the duration of the procedure ...
H. Calkins+7 more
semanticscholar +2 more sources
Coexistent Brugada Syndrome and Wolff-Parkinson-White Syndrome: What is the Optimal Management? [PDF]
Coexistent Brugada syndrome and Wolff-Parkinson-White (WPW) syndrome is rare, and as such poses management challenges. The overlap of symptoms attributable to each condition, the timing of ventricular stimulation after accessory pathway ablation and the ...
Abhishek Jaiswal, MBBS+2 more
doaj +3 more sources
MECHANISM OF THE WOLFF-PARKINSON-WHITE SYNDROME [PDF]
R. J. Duthie
openalex +5 more sources
Wolff-Parkinson-White Syndrome and Rheumatic Mitral Stenosis: an Uncommon Coincidence that can Cause Severe Hemodynamic Disturbance [PDF]
The combination of rheumatic mitral stenosis and Wolff-Parkinson-White syndrome is a rare situation. In this case, we are reporting an 72-year-old man presenting with multi-organ failure due to the this combination and successfully treated with ...
Ahmet Taha Alper+2 more
doaj +3 more sources
Percutenous Catheter Ablation of the Accessory Pathway in a Patient with Wolff-Parkinson-White Syndrome Associated with Familial Atrial Fibrillation [PDF]
Percutenous catheter ablation of the accessory pathway in Wolff-Parkinson-White syndrome is a highly successful mode of therapy. Sudden cardiac arrest survivors associated with WPW syndrome should undergo radiofrequency catheter ablation.
Serkan Cay+2 more
doaj +3 more sources
SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION [PDF]
Amiodarone is one of the basic antiarrhytmic drugs for atrial fibrillation treatment. However application of amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome can induce ventricular fibrillation. Amiodarone usage in these
D. A. Kuzhel+2 more
doaj +3 more sources